Author:
Delini-Stula A.,Radeke E.,Waldmeier P. C.
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Bieck PR, Antonin KH (1982) Monoamine oxidase inhibition by tranylcypromine: assessment in human volunteers. Eur J Clin Pharmacol 22: 301–308
2. Bieck PR, Antonin KH, Jedrychowski M (1983) Monoamine oxidase inhibition in healthy volunteers by CGP 11 305 A, a new specific inhibitor of MAO-A. Mod Probl Pharmacopsychiatry 19: 53–62
3. Bieck PR, Antonin KH, Cremer G, Gleiter C (1984) Tyramine pressor effects of CGP 11 305 A in comparison to tranylcypromine after prolonged treatment of human volunteers. In: Tipton KF, Dostert R, Strolin Benedetti M (eds) Monoamine oxidase and disease. Academic, London, pp 503–513
4. Bieck PR, Schick Ch, Antonin KH, Reimann I, Moerike K (1985) Tyramine kinetics before and after MAO inhibition with the reversible MAO inhibitor brofaromine (CGP 11 305 A). In: Boulton AA, Bieck PR, Maitre L, Riederer P (eds) Neuropsychopharmacology of the trace amines. Humana, Clifton, pp 411–426
5. Brodie BB, Pletscher A, Shore PA (1956) Possible role of serotonin in brain function and in reserpine action. J Pharmacol Exp Ther 116: 9–11
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Monoamin-Oxidase-Hemmer;Neuro-Psychopharmaka Ein Therapie-Handbuch;2002
2. Brofaromine ? a review of its pharmacological properties and therapeutic use;Journal of Neural Transmission;1996-01
3. Monoaminoxidase-Hemmer;Neuro-Psychopharmaka;1993